Agenda for Day Two - Tuesday 29 September, 2026 - CET
- Frits Stulp - Chairman of the Board, CTADHL
- Understand the current status and timeline of ICH M4Q development and what the process will look like by 2028
- Explore the shift from document-centric to data-centric CMC submissions
- Analyse IDMP integration with M4Q
- Learn about data quality specifications and their practical implications
- Manda Pasarkar - Global Regulatory Team Lead, Sanofi
- Laurent Lefebvre - Regulatory CMC Associate Director, Novartis Pharma AG
- Explore the latest AI applications and use cases in eSubmissions -
- Automated document classification
- Intelligent content extraction
- Predictive quality checks
- Submission readiness assessments
- Discover how machine learning models are reducing manual effort, improving accuracy and accelerating submission timelines while maintaining practicality
- Anastasija Serdega - Analytical Development Scientist, Autolus Therapeutics
- Establish strategic data-governance elements – including policy and standards, stewardship and accountability, and master data management – to ensure consistency and traceability
- Prepare for future IDMP implementation by aligning data models, mapping meta data and building interoperable governance frameworks
- Hear practical use cases that harmonise product and substance master data to reduce reconciliation, improve data quality and enable cross-domain interoperability
- Martin Steinmann - Senior Manager, Regulatory Data Strategy, CSL Behring
- Stefan Brügger - Senior Director, BASE Life Science
- Current status of EU-SRS the ISO/IDMP-compliant EU regulators substance database
- Update on Key IDMP implementation challenges and considerations for consistency in ISO IDMP compliant naming and capturing of pharmaceutical substances
- EU-SRS position in the National, European and Global substance data landscape
- Contribution to Global Identifiers and substance management standardisation processes
- Alignment with the M4Q and SPQS efforts for implementing structured data and future perspectives (including cloud based solutions) will be discussed
- Edyta Burda-Daghish - Chemist, BfArM
- Marcel Hoefnagel - Assessor, Biopharmaceuticals, College ter Beoordeling van Geneesmiddelen - Medicines Evaluation Board (CBG-MEB)
- Learn a concise overview of ISO IDMP and emerging European operating models, including regulator timelines, industry readiness and implications for regulatory submissions and governance
- Understand global identifier and substance-management standards, the current EU-SRS onboarding status, data reconciliation challenges and opportunities for cross-jurisdiction harmonisation
- Isabel Chicharo - Regulatory Data Management Head, European Medicines Agency (EMA)
- Raphael Sergent - Head of QA & Senior Pharma Solution Lead, Accurids
- Ese Aziza - Global Lead, Data Strategy & Management, Regulatory Affairs, Novartis
- Learn how TRS differ from traditional submission processes, their role in securing data sharing and their potential to facilitate early regulatory dialogue and reduce development timelines
- Get a status update on cloud submission capabilities at Health Authorities worldwide and practical insights into what cloud-based submissions mean for industry
- Explore ongoing TRS projects, such as Proof of Concepts (POCs) and discover decision frameworks for adopting cloud submissions to enhance efficiency and regulatory intelligence
- Claudio Schnyder - Associate Director - Submission Management, Novartis Pharma AG
- Understand the platform technology (PT) approached in the European Commission’s New Pharmaceutical Legislation (NPL) and its likely regulatory intent
- Hear first-hand experiences and real-life case studies of PT approaches implemented so far, with lessons learned and practical challenges
- Review real-life PT approaches that existed prior to the NPL proposal to identify buildable elements and proven practices
- Gain comparative insights on human v. veterinary regulatory pathways for platform technologies, noting critical differences and shared considerations
- Anticipate how platform technology provisions may evolve and adopt best-practice preparation steps (risk assessment, data strategy, governance and cross-sector coordination)
- Maren von Fritschen - Professor, University of Applied Sciences, Berlin
- Jens Pantke - Director Regulatory Digital Innovation & Operations, Moderna
- Mihai Bilanin - Global Regulatory Lead, Vaccines Development, GSK
Meeting an IDMP remediation deadline can produce a high-quality dataset. It does not keep one. Drawing on eleven expert interviews and anonymized examples from a large pharmaceutical product data programme, this session examines a recurring pattern: data used by critical business processes gets corrected, while data structured only for compliance quietly drifts. Examples cover canonical models, golden records and stewardship. Attendees will leave with a way to assess their own IDMP data.
- Matthias Sijtstra - Senior Consultant, MAIN5
- Reframe your perspective of RIM maturity as people and behavior driven and not just a technology metric
- Glean practical steps to align teams, processes and tools to foster sustainable system maturity
- Hear clear, actionable indicators to track progress and close the adoption gap
- Sabeeh Habib-Ullah - Associate Manager Regulatory Information Management, Regeneron
- Explore the strategic need for e-Portals and e-Labeling to reduce paper reliance, streamline promotional material updates and simplify global ad revisions
- Hear practical considerations, common roadblocks and collaboration strategies with local partners when building e-Labeling and e-Submissions platforms in emerging markets
- Compare regional deployment approaches and outline high-level strategies for implementing e-Portals across the EU, APAC and beyond
- Jianhui Zheng - Regulatory Affairs Senior Manager, Septodont
- Kimty Bui-Van - Global Vice President Regulatory Affairs, Septodont
- Glean modern approaches to variations, supplements and change notifications across global markets - streamline post-approval lifecycle management
- Strategies for grouping and sequencing post-approval submissions
- Digital tools for tracking submission status and regulatory commitments
- Olga Braem - Director, Global Regulatory Affairs CMC, Kyowo Kirin
This interactive roundtable brings together regulatory operations professionals who are actively engaged in RIM data cleansing. Share practical experiences and strategies to leave with actionable approaches to address your data quality challenges.
- Claudia Stump - Business Systems Manager, R&D Information and Services – Regulatory Systems and Operations, Daiichi Sankyo
- Christine Kavanagh - Manager Regulatory Information Management & Innovation, Regeneron
Join this facilitator-led roundtable to share practical strategies and leave with clear, actionable next steps to implement AI into your regulatory workflows. Tackle adoption challenges – ownership, fit-for-purpose governance and who are the AI-decision makers- while clarifying semantic alignment and validation guardrails for compliant AI.
- Niels Leander - Executive Vice President, Chief Digital Officer, PharmaRelations
IDMP isn’t just a regulatory checkbox - it's a fundamental transformation of how you structure, manage and exchange product information. This roundtable brings together regulatory operations professionals, data managers and IDMP implementation leaders who are in the trenches.
- Patrick Middag - Principal Regulatory Affairs Lead, HRIM Program, Servier
- Toni Isaacs - Data Governance, Standards & Quality – XEVMPD/IDMP, GSK
